TYMOTHI CLAUDE: Open Payments
NPI 1841718822 · LITCHFIELD PARK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 32 payments from 13 companies in 2025. Trend: 2023 $361 · 2024 $302 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 3 | $87 |
| GENZYME CORPORATION | 3 | $84 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $75 |
| ABBVIE INC. | 3 | $68 |
| Amgen Inc. | 3 | $63 |
| Organon LLC | 4 | $44 |
| Janssen Biotech, Inc. | 2 | $40 |
| Boston Scientific Corporation | 1 | $33 |
| Lilly USA, LLC | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: NEMLUVIO, DUPIXENT, SKYRIZI, OTEZLA, VTAMA, TREMFYA, Rezum Generator, TALTZ.
Industry payments across AZ — which companies pay providers there.
